UCI MIND

🎉 Congratulations to UC Irvine neuroscientist Oswald Steward for being awarded the 2026 Kavli Prize in Neuroscience, one of the world’s most prestigious honors in science. @KavliPrize @UCIMedSchool @UCIBioSci 🔖 bit.ly/4uYmUtR #KavliPrize #UCIPride

Congratulations to @UCIrvine alumna Ivanna Zuniga ('23, BA psychological science) for returning to campus as a Staff Research Associate 1, working with Associate Professor of neurology Crystal Glover at @ucimind. Ivanna was a peer tutor for psychology Professor Joanne Zinger.

Great sessions at socal #ADRC symposium - spanning microglia , fish models and tau, so important to hear novel ideas from fields outside mine to expand into #TBI ! @ucimind is at the frontier of ADRD research! Colleagues include @bill_flavin @UCIMedSchool @ucsdneurodept

@UCIrvine @HeadLab21 Go Ellie!

Women are driving discovery at UC Irvine. From cancer care to cosmic breakthroughs, UC Irvine’s female researchers are expanding the frontiers of science. uci.edu #WomensHistoryMonth

Crystal Glover, PhD, associate professor at #UCIMedSchool and the Outreach, Recruitment and Engagement Core Leader @ucimind, wants you to live a long, healthy life. Learn more about how she's working to remove obstacles to healthy aging for everyone: bit.ly/3NYZ9RZ

🩸 🧠 ⏱️ What if a blood test could predict WHEN an individual would develop symptoms of Alzheimer’s disease? High plasma p-tau217 predicts greater risk for Alzheimer’s symptoms—do the plasma p-tau217 levels provide insights into WHEN symptoms might begin? We found that after a certain level, plasma p-tau217 increased consistently across individuals and allowed creation of “clock” models that could be used to estimate age at p-tau217 abnormality (nature.com/articles/s4159…). The age at p-tau217 abnormality was strongly associated with the age that Alzheimer’s symptoms began. Interestingly, older individuals developed symptoms more quickly after p-tau217 abnormality. These models are not yet accurate enough to be useful to individuals, but we expect they can be improved by adding additional blood biomarkers and clinical features. We have created an application to view the results (amyloid.shinyapps.io/plasma_ptau217…) and shared all our code to accelerate progress. The eventual goal is to help individuals to understand their likelihood of developing Alzheimer’s symptoms. @KellenPetersen @FNIH_Org @WashUNeurology @alzassociation #ENDALZ

Could we prevent Alzheimer's before memory loss begins? Dr. Joshua Grill explains how researchers are exploring early treatment to slow or stop brain changes associated with Alzheimer’s disease in people at higher risk. Learn more about this promising area of research ➡️ bit.ly/4k3QPMP.

Today we hosted our first Ask the Doc of 2026: Reimagining clinical trials for Alzheimer's disease with Dr. Craig Stark and Casey Vanderlip youtube.com/live/4X1kcdrQH… via @YouTube

A clinical trial is testing whether early treatment with the drug lecanemab, already FDA-approved for individuals with Alzheimer's, could prevent memory loss before it starts. Dr. Joshua D. Grill of @ucimind discusses the AHEAD study, which is enrolling people with normal memory but who show early brain changes linked to Alzheimer's. Results could reshape how we approach dementia prevention. Watch the full episode: bit.ly/4k3QPMP

A $50 million gift from the Quilter family & $30 million in new commitments propel @ucimind to build state-of-the-art research & care facility for Alzheimer’s & dementia. @UCIAA Charles and Ann Quilter & family made the generous contribution. 🔗 bit.ly/4rKvFXa

@UofCalifornia @ucimind

Animated educational videos for clinicians that describe how to use biomarkers for Alzheimer's disease in clinical practice. Neurology in Motion: practicalneurology.com/videos/neurolo… via @ReachMD #ENDALZ #dementia

💜 Join us Oct 24 at the Irvine Marriott for the 36th Annual SoCal Alzheimer’s Research Conference! Hear from leading experts on genetics, pollution, psychiatric risks & more. Register: conference.mind.uci.edu #ENDALZ #OrangeCounty

🧠 🔬 New UC Irvine research by Elizabeth Andrews & Elizabeth Head suggests women with Down syndrome may face faster Alzheimer’s progression than men, a finding that could change when interventions start & how clinical trials are designed. @ucimind @UCIMedSchool Funded by @NIH

🌍 Join us: 36th Annual Southern California Alzheimer's Disease Research Conference! Dr. Jennifer Weuve reveals pollution’s hidden dementia risks: air, wildfires, noise, green space & critical life periods. 11AM • Irvine Marriott Register:conference.mind.uci.edu

On 10/4, at UCI’s Brilliant Future campaign close, Chancellor Gillman announced that UCI MIND Leadership Council members Ann and Charlie Quilter and their family: Matt, Patty, Chris, and Patrick, have made a historic $50 million gift to support UCI MIND. mind.uci.edu/blog/

💡Congrats to @ucimind for receiving an $18M, five-year grant from @NIHAging to conduct a landmark multi-center study on dementia. The award highlights @UCIrvine's position as a global leader in Alzheimer's disease and related dementias research. bit.ly/4gs4uLB

⏰ EARLY BIRD ALERT! ⏰ Save $25 ⏰ Register by 9/25 for just $100 to attend the 36th Annual Alzheimer’s Research Conference on Oct. 24 at the Irvine Marriott ! 🧠Speakers, networking, meals & more! 👉 conference.mind.uci.edu #ENDALZ #BrainHealth #EarlyBird

Scientists link sleep apnea to faster mental decline thebrighterside.news/post/scientist…